An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
Armin Mooranian,1 Rebecca Negrulj,1 Nigel Chen-Tan,2 Gerald F Watts,3 Frank Arfuso,4 Hani Al-Salami11Biotechnology and Drug Development Research Laboratory, School of Pharmacy, Curtin Health Innovation Research Institute, Biosciences Research Precinct, Curtin University, 2Faculty of Science and Engi...
Main Authors: | Mooranian A, Negrulj R, Chen-Tan N, Watts GF, Arfuso F, Al-Salami H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/an-optimized-probucol-microencapsulated-formulation-integrating-a-seco-peer-reviewed-article-DDDT |
Similar Items
-
Pharmacological and Biological Study of Microencapsulated Probucol-Secondary Bile Acid in a Diseased Mouse Model
by: Susbin Raj Wagle, et al.
Published: (2021-08-01) -
The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases
by: Arazu Sharif, et al.
Published: (2024-01-01) -
Pharmacological and Advanced Cell Respiration Effects, Enhanced by Toxic Human-Bile Nano-Pharmaceuticals of Probucol Cell-Targeting Formulations
by: Susbin Raj Wagle, et al.
Published: (2020-07-01) -
Deoxycholic Acid, a Secondary Bile Acid, Increases Cardiac Output and Blood Pressure in Rats
by: Artur Nowiński, et al.
Published: (2023-12-01) -
Influence of Bile Acids in Hydrogel Pharmaceutical Formulations on Dissolution Rate and Permeation of Clindamycin Hydrochloride
by: Nebojša Pavlović, et al.
Published: (2022-01-01)